...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Sell Zenith Shares

Yes. It is posted on Zeniths website. Go to the FAQs  and about 3/4 of the way down is a link to the letter.

Share
New Message
Please login to post a reply